SAYAKA REASONER: Open Payments
NPI 1689167637 · KAHULUI, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 38 payments from 7 companies in 2025. Trend: 2023 $141 · 2024 $678 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $263 |
| ABBVIE INC. | 7 | $144 |
| Otsuka America Pharmaceutical, Inc. | 5 | $120 |
| Teva Pharmaceuticals USA, Inc. | 5 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Lundbeck LLC | 2 | $44 |
Products named: ARISTADA, VRAYLAR, AUSTEDO XR, REXULTI, CAPLYTA, ABILIFY ASIMTUFII, COBENFY, ABILIFY MAINTENA.
Industry payments across HI — which companies pay providers there.
